Acupuncture for People at High Risk of Sepsis
Part of Infections clinical trials.
This study tests whether acupuncture can help people at high risk for sepsis, a serious infection that can lead to organ failure. If you’re 18 or older, have had a sepsis order set put in within the last two days, and are not yet in the ICU, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- A doctor placed a sepsis order-set (a special treatment plan for sepsis) for you within the last 2 days.
- You are not already in the intensive care unit (ICU).
- You do not have a pacemaker or similar implanted device that could interfere with electroacupuncture.
- You are able to give consent, or a family member or legal representative can give consent for you.
- If you are in another treatment trial, that trial’s lead doctor must say it’s okay for you to join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether gentle electrical stimulation through thin needles placed in the lower legs (electroacupuncture) can help patients fight sepsis in the ICU. It aims to see if this treatment reduces organ damage and speeds recovery.
This trial tests whether adding electroacupuncture to standard care helps people with acute respiratory distress syndrome (ARDS) in the ICU recover faster. If you have ARDS and are on a breathing machine, this study may be an option.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at a Chinese herbal injection called Xuebijing to see if certain biomarkers can predict how well it works for sepsis patients. It may help find new ways to treat sepsis more effectively.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.